Suchergebnisse - "Power, Christopher"

PubPharm (395)

51

Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period

enthalten in: AIDS (London, England) | 2021

von Rourke, S. | Bekele, T. | Rachlis, A. | +7

CommentIn: AIDS. 2021 Jun 1;35(7):1152-1153. - PMID 33946092

52

Intranasal anti‐caspase‐1 therapy preserves myelin and glucose metabolism in a model of progressive multiple sclerosis

enthalten in: Glia | 2021

von Saito, L. | Fernandes, J. | Smith, M. | +8

53

Sparse Multicategory Generalized Distance Weighted Discrimination in Ultra-High Dimensions

enthalten in: Entropy (Basel, Switzerland) | 2020

von Su, T. | Wang, Y. | Liu, Y. | +6

54

Lifetime antiretroviral exposure and neurocognitive impairment in HIV

enthalten in: Journal of neurovirology | 2020

von Amusan, P. | Power, C. | Gill, M. | +4

55

Activation of the executioner caspases-3 and -7 promotes microglial pyroptosis in models of multiple sclerosis

enthalten in: Journal of neuroinflammation | 2020

von McKenzie, B. | Fernandes, J. | Doan, M. | +3

56

Activation of the executioner caspases-3 and -7 promotes microglial pyroptosis in models of multiple sclerosis

enthalten in: Journal of neuroinflammation | 2020

von McKenzie, B. | Fernandes, J. | Doan, M. | +3

57

Activation of the executioner caspases-3 and -7 promotes microglial pyroptosis in models of multiple sclerosis

enthalten in: Journal of neuroinflammation | 2020

von McKenzie, B. | Fernandes, J. | Doan, M. | +3

58

Lifetime antiretroviral exposure and neurocognitive impairment in HIV

enthalten in: Journal of neurovirology | 2020

von Amusan, P. | Power, C. | Gill, M. | +4

59

Lifetime antiretroviral exposure and neurocognitive impairment in HIV

enthalten in: Journal of neurovirology | 2020

von Amusan, P. | Power, C. | Gill, M. | +4

60

Lifetime antiretroviral exposure and neurocognitive impairment in HIV

enthalten in: Journal of neurovirology | 2020

von Amusan, P. | Power, C. | Gill, M. | +4